A study led by Dr. Andrew Stephens from the Prince Henry’s Institute has discovered a process that is associated with inflammation in cancers. This discovery could lead to expanded treatment options for some types of ovarian cancer tumors. Monash Health, Hasanuddin University, Indonesia and Lincoln Research Centre, Christchurch also participated in the study which was posted in the International Journal of Cancer.
Related Topics
OCRA-Funded Research Identifies Promising Therapeutic Strategy to Improve Immune Response Against Ovarian Cancer
A study recently published in Science Advances and supported in part by Ovarian Cancer Research Alliance has advanced scientists’ understanding of how to potentially overcome immune evasion in ovarian cancer. … Continued
BBC Features OCRA-Funded Research in AI Breakthroughs Series
OCRA-funded research using artificial intelligence (AI) for ovarian cancer early detection was highlighted in the BBC’s six-part series on how AI is transforming medicine. Dr. Daniel Heller, an OCRA-funded researcher … Continued
OCRA-Funded Research Makes Inroads Toward Effective CAR T-Cell Therapies
A research team, led by Dr. Ugo Cavallaro and supported by OCRA’s 2019 Collaborative Research Development Grant, made progress toward improving immunotherapies for ovarian cancer. Dr. Frances R. Balkwill, a … Continued